- Home
- XERS vs FSBC Comparison
XERS vs FSBC Comparison
Compare XERS & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XERS | FSBC |
|---|---|---|
| Founded | 2005 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 965.6M | 821.1M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | XERS | FSBC |
|---|---|---|
| Price | $5.47 | $36.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $10.43 | ★ $40.75 |
| AVG Volume (30 Days) | ★ 2.1M | 65.3K |
| Earning Date | 05-18-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.72% |
| EPS Growth | ★ 100.00 | 28.32 |
| EPS | N/A | ★ 2.90 |
| Revenue | ★ $49,590,000.00 | N/A |
| Revenue This Year | $28.65 | $29.27 |
| Revenue Next Year | $18.33 | $12.35 |
| P/E Ratio | ★ N/A | $12.68 |
| Revenue Growth | ★ 142.67 | N/A |
| 52 Week Low | $3.81 | $22.22 |
| 52 Week High | $10.08 | $42.26 |
Technical Indicators
Market Signals| Indicator | XERS | FSBC |
|---|---|---|
| Relative Strength Index (RSI) | 26.31 | 29.75 |
| Support Level | $4.30 | $36.20 |
| Resistance Level | $5.49 | $38.25 |
| Average True Range (ATR) | 0.34 | 1.36 |
| MACD | -0.06 | -0.39 |
| Stochastic Oscillator | 3.62 | 12.25 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.